These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 26083004

  • 21. Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.
    Milling TJ, Fromm C, Ganetsky M, Pallin DJ, Cong J, Singer AJ.
    Ann Emerg Med; 2017 May; 69(5):531-540. PubMed ID: 28196608
    [Abstract] [Full Text] [Related]

  • 22. [New oral anticoagulants in patients with atrial fibrillation in a urban health center].
    Rodríguez Pérez L, Capilla Lozano F, Gallego Fuentes R, Buitrago F.
    Med Clin (Barc); 2016 Mar 18; 146(6):280-1. PubMed ID: 26343157
    [No Abstract] [Full Text] [Related]

  • 23. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation.
    Scott KA, Amirehsani KA.
    J Am Assoc Nurse Pract; 2015 Apr 18; 27(4):190-6. PubMed ID: 25066647
    [Abstract] [Full Text] [Related]

  • 24. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
    Ritzenthaler T, Derex L, Davenas C, Bnouhanna W, Farghali A, Mechtouff L, Cho TH, Nighoghossian N.
    Rev Neurol (Paris); 2015 Sep 18; 171(8-9):613-5. PubMed ID: 25857461
    [Abstract] [Full Text] [Related]

  • 25. Safety of electroconvulsive therapy in patients receiving dabigatran therapy.
    Schmidt ST, Lapid MI, Sundsted KK, Cunningham JL, Ryan DA, Burton MC.
    Psychosomatics; 2014 Sep 18; 55(4):400-403. PubMed ID: 23932534
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab-A Case Report.
    Schäfer N, Müller A, Wüllner U.
    J Stroke Cerebrovasc Dis; 2016 Aug 18; 25(8):e126-7. PubMed ID: 27236361
    [Abstract] [Full Text] [Related]

  • 28. Palmoplantar pustular eruption due to dabigatran.
    Schleichert R, Goldner R, Dickfeld T.
    Cutis; 2016 May 18; 97(5):E10-1. PubMed ID: 27274551
    [No Abstract] [Full Text] [Related]

  • 29. Adherence in patients with atrial fibrillation treated with dabigatran.
    Grześk G, Janiszewska E, Malinowski B, Kubica A, Wiciński M.
    Kardiol Pol; 2018 May 18; 76(11):1562-1563. PubMed ID: 30211436
    [No Abstract] [Full Text] [Related]

  • 30. Hemopericardium under dabigatran for stroke prevention in atrial fibrillation.
    Stöllberger C, Heger M, Finsterer J.
    Blood Coagul Fibrinolysis; 2017 Mar 18; 28(2):185-188. PubMed ID: 26945264
    [Abstract] [Full Text] [Related]

  • 31. Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding.
    Quintard H, Viard D, Drici MD, Ruetsch C, Samama CM, Ichai C.
    Thromb Haemost; 2017 Jan 05; 117(1):196-197. PubMed ID: 27734073
    [No Abstract] [Full Text] [Related]

  • 32. Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.
    Beyer-Westendorf J, Ebertz F, Förster K, Gelbricht V, Michalski F, Köhler C, Werth S, Endig H, Pannach S, Tittl L, Sahin K, Daschkow K, Weiss N.
    Thromb Haemost; 2015 Jun 05; 113(6):1247-57. PubMed ID: 25739533
    [Abstract] [Full Text] [Related]

  • 33. Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
    Rosenberg L, Gerstrøm G, Nybo M.
    Basic Clin Pharmacol Toxicol; 2017 Apr 05; 120(4):407-410. PubMed ID: 27797449
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
    Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S.
    Stroke; 2017 Jan 05; 48(1):159-166. PubMed ID: 27909200
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Dabigatran specific antidote: new safety level in oral anticoagulation].
    MMW Fortschr Med; 2015 Nov 05; 157(19):78-9. PubMed ID: 26953416
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.